FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

12/3/25 6:19:09 AM ET

$PM

$RACE

Medicinal Chemicals and Botanical Products

Health Care

Auto Manufacturing

Industrials

Get the next $PM alert in real time by email

Maranello (Italy), December 3, 2025 – Ferrari N.V. (NYSE/EXM: RACE) ("Ferrari" or "the Company") announced today that Ferrari S.p.A., its wholly-owned Italian subsidiary, has renewed and strengthened its multi-year partnership with Philip Morris International (NYSE:PM).

Under the agreement – signed today and taking effect on January 1, 2026 – Philip Morris International becomes a Premium Partner of Scuderia Ferrari HP and a Series Partner of the Ferrari Challenge Trofeo Pirelli, continuing a collaboration that has spanned more than 50 years.

For further information:

Media Relations

tel.: +39 0536 949337

Email: [email protected]

Attachment

CS_FNV_PMI_ENG

Get the next $PM alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$PM
$RACE

Company	Date	Price Target	Rating	Analyst
Philip Morris International Inc $PM	1/20/2026	$180.00	Buy → Hold	Jefferies
Ferrari N.V. $RACE	1/13/2026		Buy → Hold	HSBC Securities
Ferrari N.V. $RACE	12/8/2025	$425.00	Overweight → Equal-Weight	Morgan Stanley
Ferrari N.V. $RACE	10/2/2025	$470.00	Hold → Buy	HSBC Securities
Ferrari N.V. $RACE	9/16/2025		Buy	Berenberg
Ferrari N.V. $RACE	9/2/2025		Hold → Buy	Deutsche Bank
Philip Morris International Inc $PM	7/9/2025	$220.00	Buy	Jefferies
Philip Morris International Inc $PM	5/22/2025	$195.00	Buy	Needham

More analyst ratings

$PM
$RACE
Press Releases

Fastest customizable press release news feed in the world

View All

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Maranello (Italy), February 2 2026 – Ferrari N.V. (NYSE/EXM: RACE) ("Ferrari" or the "Company") informs that the Company has purchased, under the Euro 250 million share buyback program announced on December 16, 2025, as the first tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the "First Tranche"), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) as follows: TradingDate(dd/mm/yyyy) Stock Exchange Number of common shares purchased Average price per shareexcluding fees(€) Consideration excluding fee

2/2/26 11:57:48 AM ET

$RACE

Auto Manufacturing

Industrials

Philip Morris International to Host Webcast of 2025 Fourth-Quarter and Full-Year Results

Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) will host a live audio webcast on Friday, February 6, 2026, at 9:00 a.m. ET, to discuss its 2025 Fourth-Quarter and Full-Year financial results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast can be accessed here. The webcast will be hosted by Jacek Olczak, Group CEO PMI, and Emmanuel Babeau, Group Chief Financial Officer, and will include discussion of PMI's financial results and a Q&A session with the investment community. The webcast will be in a listen-only mode. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The we

1/30/26 8:00:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

Philip Morris International Urges FDA Advisory Committee to Recommend Authorizing ZYN as a Modified Risk Tobacco Product

In January 2025, ZYN became the first nicotine pouch product authorized for marketing by the FDA Experts from Philip Morris International (PMI) (NYSE:PM) yesterday presented scientific evidence to the U.S. Food and Drug Administration's (FDA) Tobacco Products Scientific Advisory Committee (TPSAC) as part of the FDA's process for a Modified Risk Tobacco Product (MRTP) designation for their ZYN nicotine pouch products. This designation would allow PMI's U.S. family of businesses to communicate to U.S. legal-aged, 21+ adult cigarette smokers that switching completely to ZYN reduces their risk of many smoking-related diseases and we look forward to a decision by FDA. "The FDA's Center for T

1/23/26 9:15:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

$PM
$RACE
Leadership Updates

Live Leadership Updates

View All

Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

The paper calls for global debate to ensure AI enhances—rather than diminishes—uniquely human strengths in an increasingly automated world Philip Morris International Inc. (NYSE:PM) today released a new white paper, "Human Cognition: The Next Frontier?", inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the "superskill" of the future, driving progress in an era of human-machine collaboration. As AI automates routine ta

1/20/26 5:03:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex

9/17/24 9:11:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

Philip Morris International Names New External Affairs Leader

Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what

3/26/24 5:48:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

$PM
$RACE
Financials

Live finance-specific insights

View All

2026 CORPORATE CALENDAR

Maranello (Italy), 15 January 2026 - Ferrari N.V. (the "Company") (NYSE/EXM: RACE) announced today the following corporate calendar for year 20261: Earnings Releases 10 February 2026 - Group results for 4th quarter and full-year 20255 May 2026 - Group results for 1st quarter 202630 July 2026 - Group results for 2nd quarter 20263 November 2026 - Group results for 3rd quarter 2026 A conference call for financial analysts is also planned on the date of each earnings release. Listen only live webcasts of the presentations as well as related materials will be accessible on the Company's corporate website (https://www.ferrari.com/en-EN/corporate).The Annual General Meeting for the approval of t

1/15/26 6:41:10 AM ET

$RACE

Auto Manufacturing

Industrials

FERRARI TO ANNOUNCE 2025 FULL YEAR AND FOURTH QUARTER FINANCIAL RESULTS ON FEBRUARY 10

Maranello (Italy), January 8, 2026 - Ferrari N.V. ("Ferrari") (NYSE/EXM: RACE) announced today that its financial results for the full year and fourth quarter of 2025 will be released on Tuesday, February 10, 2026. A live audio webcast and conference call of the 2025 full year and fourth quarter results will begin at 2:00 p.m. GMT / 3:00 p.m. CET / 9:00 a.m. EST on Tuesday, February 10. Details for accessing this presentation will be available in the Investors section of Ferrari's corporate website at https://www.ferrari.com/en-EN/corporate prior to the event. Please note that registering in advance is required to access the conference call details. For those unable to participate in the l

1/8/26 6:29:45 AM ET

$RACE

Auto Manufacturing

Industrials

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on January 14, 2026, to shareholders of record as of December 26, 2025. The ex-dividend date is December 26, 2025. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio prim

12/12/25 7:00:00 AM ET

$PM

Medicinal Chemicals and Botanical Products

Health Care

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PM
$RACE

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PM
$RACE

$PM
$RACE
Insider Trading

New insider Trumpaitis Mindaugas claimed ownership of 73,002 shares (SEC Form 3)

Director Temperley Dessislava was granted 1,002 shares, increasing direct ownership by 15% to 7,756 units (SEC Form 4)

Director Bough Bonin was granted 1,002 shares, increasing direct ownership by 11% to 9,834 units (SEC Form 4)

$PM
$RACE
Analyst Ratings

Philip Morris International downgraded by Jefferies with a new price target

Ferrari downgraded by HSBC Securities

Ferrari downgraded by Morgan Stanley with a new price target

$PM
$RACE
SEC Filings

SEC Form 6-K filed by Ferrari N.V.

SEC Form 6-K filed by Ferrari N.V.

SEC Form 6-K filed by Ferrari N.V.

$PM
$RACE
Press Releases

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Philip Morris International to Host Webcast of 2025 Fourth-Quarter and Full-Year Results

Philip Morris International Urges FDA Advisory Committee to Recommend Authorizing ZYN as a Modified Risk Tobacco Product

$PM
$RACE
Leadership Updates

Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Philip Morris International Names New External Affairs Leader

$PM
$RACE
Financials

2026 CORPORATE CALENDAR

FERRARI TO ANNOUNCE 2025 FULL YEAR AND FOURTH QUARTER FINANCIAL RESULTS ON FEBRUARY 10

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

$PM
$RACE
Large Ownership Changes

SEC Form SC 13G/A filed by Ferrari N.V. (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $PM$RACE

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $PM$RACE

$PM$RACE Insider Trading

New insider Trumpaitis Mindaugas claimed ownership of 73,002 shares (SEC Form 3)

Director Temperley Dessislava was granted 1,002 shares, increasing direct ownership by 15% to 7,756 units (SEC Form 4)

Director Bough Bonin was granted 1,002 shares, increasing direct ownership by 11% to 9,834 units (SEC Form 4)

$PM$RACE Analyst Ratings

Philip Morris International downgraded by Jefferies with a new price target

Ferrari downgraded by HSBC Securities

Ferrari downgraded by Morgan Stanley with a new price target

$PM$RACE SEC Filings

SEC Form 6-K filed by Ferrari N.V.

SEC Form 6-K filed by Ferrari N.V.

SEC Form 6-K filed by Ferrari N.V.

$PM$RACE Press Releases

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Philip Morris International to Host Webcast of 2025 Fourth-Quarter and Full-Year Results

Philip Morris International Urges FDA Advisory Committee to Recommend Authorizing ZYN as a Modified Risk Tobacco Product

$PM$RACE Leadership Updates

Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Philip Morris International Names New External Affairs Leader

$PM$RACE Financials

2026 CORPORATE CALENDAR

FERRARI TO ANNOUNCE 2025 FULL YEAR AND FOURTH QUARTER FINANCIAL RESULTS ON FEBRUARY 10

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

$PM$RACE Large Ownership Changes

SEC Form SC 13G/A filed by Ferrari N.V. (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

Recent Analyst Ratings for
$PM
$RACE

Recent Analyst Ratings for
$PM
$RACE

$PM
$RACE
Insider Trading

$PM
$RACE
Analyst Ratings

$PM
$RACE
SEC Filings

$PM
$RACE
Press Releases

$PM
$RACE
Leadership Updates

$PM
$RACE
Financials

$PM
$RACE
Large Ownership Changes